Literature DB >> 12869655

Molecular determinants of Ca2+ potentiation of diltiazem block and Ca2+-dependent inactivation in the pore region of cav1.2.

Nejmi Dilmac1, Nathan Hilliard, Gregory H Hockerman.   

Abstract

Diltiazem block of Cav1.2 is frequency-dependent and potentiated by Ca2+. We examined the molecular determinants of these characteristics using mutations that affect Ca2+ interactions with Cav1.2. Mutant and wild-type (WT) Cav1.2 channels were transiently expressed in tsA 201 cells with beta1b and alpha2delta subunits. The four conserved glutamates that compose the Ca2+ selectivity filter in Cav1.2 were mutated to Gln (E363Q, E709Q, E1118Q, E1419Q), and each single mutant was assayed for block by diltiazem using whole-cell voltage-clamp recordings in either 10 mM Ba2+ or 10 mM Ca2+. In Ba2+, none of the mutations affected the potency of diltiazem block of closed channels (0.05 Hz stimulation). However, frequency-dependent block (1Hz stimulation) was eliminated in the mutant E1419Q (domain IV), which recovered more rapidly than WT channels from inactivated channel block. Potentiation of diltiazem block of closed Cav1.2 channels in Ca2+ was abolished in the E1118Q, F1117G (domain III), and E1419Q mutants. Frequency-dependent block in Ca2+ was reduced compared with WT Cav1.2 in the F1117G, E1118Q, and E1419Q mutants. The C-terminal tail IQ domain mutation I1627A, which disrupts Ca2+ dependent inactivation, enhanced diltiazem block of closed channels in Ba2+. We conclude that, in Ba2+, E1419 slows recovery from diltiazem block of depolarized Cav1.2 channels, but in Ca2+, E1118, E1419, and F1117 form a Ca2+ binding site that mediates the potentiation of diltiazem block of both closed and inactivated Cav1.2 channels. Furthermore, Ca2+-dependent inactivation, which is impaired in E709Q, E1118Q, E1419Q, and I1627A, is not required for Ca2+ potentiation of diltiazem block.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12869655     DOI: 10.1124/mol.64.2.491

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  9 in total

1.  Alternative splicing modulates diltiazem sensitivity of cardiac and vascular smooth muscle Ca(v)1.2 calcium channels.

Authors:  Heng Yu Zhang; Ping Liao; Jue Jin Wang; De Jie Yu; Tuck Wah Soong
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

2.  Distinct properties of amlodipine and nicardipine block of the voltage-dependent Ca2+ channels Cav1.2 and Cav2.1 and the mutant channels Cav1.2/dihydropyridine insensitive and Cav2.1/dihydropyridine sensitive.

Authors:  Min Lin; Oluyemi Aladejebi; Gregory H Hockerman
Journal:  Eur J Pharmacol       Date:  2011-09-02       Impact factor: 4.432

3.  Structural Basis for Diltiazem Block of a Voltage-Gated Ca2+ Channel.

Authors:  Lin Tang; Tamer M Gamal El-Din; Michael J Lenaeus; Ning Zheng; William A Catterall
Journal:  Mol Pharmacol       Date:  2019-08-07       Impact factor: 4.436

4.  Structural modeling of calcium binding in the selectivity filter of the L-type calcium channel.

Authors:  Ricky C K Cheng; Denis B Tikhonov; Boris S Zhorov
Journal:  Eur Biophys J       Date:  2010-01-07       Impact factor: 1.733

5.  A single amino acid change in Ca(v)1.2 channels eliminates the permeation and gating differences between Ca(2+) and Ba(2+).

Authors:  Zhe Li; Xianming Wang; Guofeng Gao; Dongmei Qu; Buwei Yu; Congxin Huang; Keith S Elmslie; Blaise Z Peterson
Journal:  J Membr Biol       Date:  2010-01-23       Impact factor: 1.843

6.  New Generation Calcium Channel Blockers in Hypertensive Treatment.

Authors:  Yuri Ozawa; Koichi Hayashi; Hiroyuki Kobori
Journal:  Curr Hypertens Rev       Date:  2006-05-01

7.  Interaction of diltiazem with an intracellularly accessible binding site on Ca(V)1.2.

Authors:  W Shabbir; S Beyl; E N Timin; D Schellmann; T Erker; A Hohaus; G H Hockerman; S Hering
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

8.  Development of phenotypic assays for identifying novel blockers of L-type calcium channels in neurons.

Authors:  Rebecca Hagan; Elizabeth Rex; David Woody; Monika Milewski; Thomas Glaza; Michael P Maher; Yi Liu
Journal:  Sci Rep       Date:  2021-01-11       Impact factor: 4.379

9.  Diltiazem inhibits SARS-CoV-2 cell attachment and internalization and decreases the viral infection in mouse lung.

Authors:  Xinxin Wang; Jie Luo; Zhiyuan Wen; Lei Shuai; Chong Wang; Gongxun Zhong; Xijun He; Huizhen Cao; Renqiang Liu; Jinying Ge; Ronghong Hua; Ziruo Sun; Xijun Wang; Jinliang Wang; Zhigao Bu
Journal:  PLoS Pathog       Date:  2022-02-17       Impact factor: 6.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.